Menopause  >>  goserelin acetate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT00235937: Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex

Completed
2
45
Europe
Anastrozole and goserelin
AstraZeneca
Breast Cancer
 
12/06
NCT00303524: Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

Completed
2
170
Japan
Goserelin acetate, Zoladex
AstraZeneca
Breast Cancer
08/07
02/09
NCT00196846 / 2004-003980-62: Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)

Completed
2
62
Europe
Goserelin
German Breast Group
Breast Cancer
12/08
03/10
NCT00322348 / 2005-004001-29: Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women

Completed
2
98
Europe, RoW
Goserelin acetate, Zoladex®
AstraZeneca
Advanced Breast Cancer
 
11/09

Download Options